Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ticagrelor on the adenosine system in healthy volunteers
2012-004560-21Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ticagrelor, sponsored by Radboud University Medical Center. Primary endpoints: Forearm blood flow response to intrabrachial adenosine and Forearm blood flow response to post-occlusive reactive hyperemia. Started Feb 2013; status: completed.
02
Drugs
ticagrelor
Beyond the preview
Go deeper on 2012-004560-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004560-21.